A Kumar, SS D'Souza, AS Thakur - Stem cells international, 2019 - Wiley Online Library
Hematopoietic stem cells (HSCs) surface during embryogenesis leading to the genesis of the hematopoietic system, which is vital for immune function, homeostasis balance, and …
Human hematopoietic stem cells (HSCs), which arise from aorta-gonad-mesonephros (AGM), are widely used to treat blood diseases and cancers. However, a technique for their …
Background Human induced pluripotent stem cells (hiPSCs) offer a renewable source of cells for the generation of hematopoietic cells for cell-based therapy, disease modeling, and …
Adoptive cell therapy (ACT) using chimeric antigen receptor (CAR) T cells holds impressive clinical outcomes especially in patients who are refractory to other kinds of therapy …
SS D'Souza, A Kumar, J Weinfurter, MA Park, J Maufort… - Stem cell reports, 2022 - cell.com
Adoptive therapies with genetically modified somatic T cells rendered HIV resistance have shown promise for AIDS therapy. A renewable source of HIV-resistant human T cells from …
K Alsayegh, LV Cortés-Medina… - Current …, 2019 - ingentaconnect.com
Numerous human disorders of the blood system would directly or indirectly benefit from therapeutic approaches that reconstitute the hematopoietic system. Hematopoietic stem …
Induced pluripotent stem cell (iPSC)-derived T (iT) cells represent a groundbreaking frontier in adoptive cell therapies with engineered T cells, poised to overcome pivotal limitations …
Fate decisions in the embryo are controlled by a plethora of microenvironmental interactions in a three‐dimensional niche. To investigate whether aspects of this microenvironmental …
JM Lee - International Journal of Molecular Sciences, 2019 - mdpi.com
The generation of immune cells from human pluripotent stem cells (embryonic stem cells and induced pluripotent stem cells) has been of keen interest to regenerative medicine …